Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence
Sebastian Cole, Paul Campitelli, Brian Grieb, Igor Astsaturov, Daniel Von Hoff, Harshabad Singh, Michael J. Pishvaian, Tanios S. Bekaii-Saab, Peter J. Hosein, Philip A. Philip, Anthony Helmstetter, Todd Maney, Jennifer R. Ribeiro, James Hamrick, Daniel Magee, David Spetzler · 2026
Read Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence by Sebastian Cole, Paul Campitelli, Brian Grieb, Igor Astsaturov, Daniel Von Hoff, Harshabad Singh, Michael J. Pishvaian, Tanios S. Bekaii-Saab, Peter J. Hosein, Philip A. Philip, Anthony Helmstetter, Todd Maney, Jennifer R. Ribeiro, James Hamrick, Daniel Magee, David Spetzler (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13507153.txt.
Description
Sebastian Cole and colleagues build, in 2026 work, an AI model to guide first drug choice in advanced pancreatic cancer, a disease with poor outcomes. Two standard options exist: a strong multi-drug mix often called FOLFIRINOX, and a gentler pair based on gemcitabine. Older or frail patients usually get the gentler pair, yet no full method sorts who benefits most from each.
The model learned from gene activity in 2202 profiled tumors, with matched comparisons to limit bias. Patients flagged for the strong mix lived longer and stayed on first therapy longer when they actually got it first. About half of patients had received the opposite of the model advice. Routine tumor profiling could host this guide.
Catalog record
| CREATOR | Sebastian Cole, Paul Campitelli, Brian Grieb, Igor Astsaturov, Daniel Von Hoff, Harshabad Singh, Michael J. Pishvaian, Tanios S. Bekaii-Saab, Peter J. Hosein, Philip A. Philip, Anthony Helmstetter, Todd Maney, Jennifer R. Ribeiro, James Hamrick, Daniel Magee, David Spetzler |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54743 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |